EUVIMEDEUVIMED entdecken
Vergleichsstudie

Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images

Tatsuya Gotoh iD, Takashi Kumada iD, Sadanobu Ogawa iD, Fumihiko Niwa iD, Hidenori Toyoda iD, Masashi Hirooka iD, Yohei Koizumi iD, Yoichi Hiasa iD, Tomoyuki Akita iD, Junko Tanaka iD, Masahito Shimizu iD

Liver International · 2025

DOI: 10.1111/liv.16210 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Liver International, 2025. Verfasst von Tatsuya Gotoh und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Imaging Diagnosis, Ogaki Municipal Hospital, Ogaki, Japan. Hauptthemen laut MEDLINE: Magnetic Resonance Imaging, Algorithms, Liver. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: FUJIFILM Corporation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims This study prospectively compared the diagnostic accuracies of the improved Attenuation Measurement (iATT) algorithm and the Controlled Attenuation Parameter (CAP) and assessed the interchangeability of iATT with magnetic resonance imaging‐derived proton density fat fraction (MRI‐derived PDFF).

Methods

Patients with chronic liver disease were prospectively enrolled and underwent iATT, CAP and MRI‐derived PDFF measurements for hepatic steatosis evaluation. According to MRI‐derived PDFF values, steatosis grades were categorised as steatosis (S)0 (< 5.2%), S1 (≥ 5.2%, < 11.3%), S2 (≥ 11.3%, < 17.1%) and S3 (≥ 17.1%). Correlation coefficients (CCs) were determined, diagnostic performances were compared by the area under the receiver operating characteristic curve (AUROC) and agreement was evaluated using the calculated percentage error (PE) and expected limit of agreement (LOA).

Results

A total of 414 patients (median age 64 years, 203 females) were evaluated. The CC between iATT and MRI‐derived PDFF was 0.727 (95% confidence interval [CI] 0.678–0.770), which was higher than that between CAP and MRI‐derived PDFF at 0.615 (95% CI 0.551–0.672) ( p < 0.001). The AUROCs of iATT for ≥ S1, ≥ S2 and ≥ S3 were 0.901 (95% CI 0.870–0.931), 0.878 (95% CI 0.846–0.910) and 0.839 (95% CI 0.794–0.883), respectively. The diagnostic performances of iATT for ≥ S1 and ≥ S2 showed significantly higher AUROCs than those of CAP ( p < 0.001, p = 0.036, respectively). The calculated PE and the expected LOA for CAP and iATT were 38.94% and 22.66% and 32.94% and 30.03%, respectively. Conclusions iATT was superior to CAP and comparable to MRI‐derived PDFF in assessing hepatic steatosis. Trial Registration This study was registered in the University Hospital Medical Information Network (UMIN) Clinical Trials Registry (UMIN000047411)

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Magnetic Resonance ImagingAlgorithmsLiverHumansFemaleMaleMiddle AgedProspective StudiesAgedROC CurveFatty LiverNon-alcoholic Fatty Liver DiseaseAdult

Stichwörter der Autor:innen

Bland‐Altman analysisMRI‐derived proton density fat fractionattenuation coefficientattenuation measurementcontrolled attenuation parameterhepatic steatosis

Autor:innen und Institutionen

  • Department of Imaging Diagnosis, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Nursing, Faculty of Nursing, Gifu Kyoritsu University, Ogaki, Japan.
  • Department of Gastroenterology and Hepatology, Ogaki Municipal Hospital, Ogaki, Japan.
  • Department of Gastroenterology and Metabiology, Ehime University Graduate School of Medicine, Ehime, Japan.
  • Department of Epidemiology, Infectious Disease Control and Prevention, Hiroshima University Institute of Biomedical and Health Sciences, Hiroshima, Japan.
  • Department of Gastroenterology/Internal Medicine, Graduate School of Medicine, Gifu University, Gifu, Japan.

ORCID-Profile: Tatsuya Gotoh, Takashi Kumada, Sadanobu Ogawa, Fumihiko Niwa, Hidenori Toyoda, Masashi Hirooka, Yohei Koizumi, Yoichi Hiasa, Tomoyuki Akita, Junko Tanaka, Masahito Shimizu

Förderung

  • FUJIFILM Corporation

Zitieren

APA

Gotoh, T., Kumada, T., Ogawa, S., Niwa, F., Toyoda, H., Hirooka, M., Koizumi, Y., Hiasa, Y., Akita, T., Tanaka, J., & Shimizu, M. (2025). Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images. Liver International. https://doi.org/10.1111/liv.16210

Vancouver

Gotoh T, Kumada T, Ogawa S, Niwa F, Toyoda H, Hirooka M, et al. Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images. Liver International. 2025. doi:10.1111/liv.16210

BibTeX
@article{Gotoh2025,
  author = {Gotoh, Tatsuya and Kumada, Takashi and Ogawa, Sadanobu and Niwa, Fumihiko and Toyoda, Hidenori and Hirooka, Masashi and Koizumi, Yohei and Hiasa, Yoichi and Akita, Tomoyuki and Tanaka, Junko and Shimizu, Masahito},
  title = {Comparison Between Attenuation Measurement and the Controlled Attenuation Parameter for the Assessment of Hepatic Steatosis Based on MRI Images},
  journal = {Liver International},
  year = {2025},
  doi = {10.1111/liv.16210}
}
Kostenlos starten →